Security challenges are ever evolving; monitoring signatures and behaviors is no longer enough..
Powered by unsupervised machine learning and probabilistic mathematics developed by specialists from the University of Cambridge, Darktrace’s Enterprise Immune System detects previously-unidentified threats within networks, in real time. The technology does this by learning the ‘self’ of an organisation, understanding deviations from the normal ‘pattern of life’, without relying on prior knowledge, rules or assumptions.
The Enterprise Immune System is considered the de facto technological solution for proactively defending against insider cyber-threats. Over 250 organisations around the world rely on Darktrace to help protect complex, constantly-evolving information networks, across a wide range of industry sectors including energy and critical infrastructure, telecommunications, financial services, the legal sector, healthcare, retail, and media.
Darktrace is one of the world’s fastest-growing cyber-threat defence companies, widely recognised for its innovative technology. Winner of the Queen’s Award for Enterprise Innovation in 2016, Darktrace was also named ‘Technology Pioneer 2015’ by the World Economic Forum and ‘Business Innovator 2016’ by Bloomberg.
The Darktrace Team:
Combines unique expertise across the fields of mathematics, software and government intelligence, allowing to deliver unparalleled technology to our customers across the world. Their senior analysts have worked at the NSA, MI5 and GCHQ, with experience addressing some of the most advanced cyber-attacks against national governments and critical infrastructure.
Darktrace is backed by world-class advisors and investors from the technology, business and cyber security domains. The company’s advisory board includes Lord Evans of Weardale KCB, former Director-General of the British security service MI5, Alan Wade, former CIO of the CIA and Dr Mike Lynch OBE, founder of Invoke Capital and Autonomy. The board of directors is chaired by Robert Webb QC, former General Counsel of Rolls Royce and British Airways.
Using new machine learning techniques based on the biological principles of the human immune system, Darktrace addresses the challenge of detecting previously unidentified cyber threats, irrespective of their origin.
Key benefits of Darktrace’s Enterprise Immune System Technology
- Self-learning – constantly refines its understanding of normal
- Adaptive – evolves with your organisation
- Probabilistic – understands the likelihood of a threat
- Real-time – detects threats as they emerge
- Works from day one – delivers instant value
- No false positives – refined correlation of weak indicators
- Data agnostic – ingests all data sources
- Highly accurate – models human, device and enterprise behaviour
Interested in finding out how Darktrace will work within your environment?
Book a Proof of Value!
A Proof of Value (POV) is a unique, easy four-week trial that allows you to evaluate Darktrace’s Enterprise Immune System and Threat Visualizer within your own environment. The POV allows organizations to understand why some of the world’s leading companies are relying on Darktrace to gain unprecedented visibility into their networks and detect emerging cyber threats within their systems in real time – before they develop into damaging incidents. Our experienced team will install a Darktrace appliance within your environment in just one day, and give you access to our groundbreaking Threat Visualizer interface. During the POV, you will also receive detailed updates on what we find, produced by our world-leading cyber analysts.